Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

2.

Reactive oxygen species and the mitochondrial signaling pathway of cell death.

Le Bras M, Clément MV, Pervaiz S, Brenner C.

Histol Histopathol. 2005 Jan;20(1):205-19. Review.

PMID:
15578439
3.

Regulation and interplay of apoptotic and non-apoptotic cell death.

Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, Arihiro K.

J Pathol. 2006 Feb;208(3):319-26. Review.

PMID:
16261658
4.

Induction of apoptosis via the modulation of reactive oxygen species (ROS) production in the treatment of myeloid leukemia.

Kizaki M, Xian M, Sagawa M, Ikeda Y.

Curr Pharm Biotechnol. 2006 Oct;7(5):323-9. Review.

PMID:
17076648
5.

Reactive oxygen species in mitochondria-mediated cell death.

Orrenius S.

Drug Metab Rev. 2007;39(2-3):443-55. Review.

PMID:
17786631
6.

ROS stress in cancer cells and therapeutic implications.

Pelicano H, Carney D, Huang P.

Drug Resist Updat. 2004 Apr;7(2):97-110. Review.

PMID:
15158766
7.

Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Moreno-Sánchez R.

Mol Aspects Med. 2010 Feb;31(1):29-59. doi: 10.1016/j.mam.2009.12.006. Epub 2009 Dec 21. Review.

PMID:
20026172
8.

The cancer cell's "power plants" as promising therapeutic targets: an overview.

Pedersen PL.

J Bioenerg Biomembr. 2007 Feb;39(1):1-12. Review.

PMID:
17404823
9.

Chemotherapy through mitochondrial apoptosis using nutritional supplements and herbs: a brief overview.

Kwon KB, Park BH, Ryu DG.

J Bioenerg Biomembr. 2007 Feb;39(1):31-4. Review.

PMID:
17549640
10.

Mechanisms of fenretinide-induced apoptosis.

Hail N Jr, Kim HJ, Lotan R.

Apoptosis. 2006 Oct;11(10):1677-94. Review.

PMID:
16850162
11.

Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

Buytaert E, Dewaele M, Agostinis P.

Biochim Biophys Acta. 2007 Sep;1776(1):86-107. Epub 2007 Jul 6. Review.

PMID:
17693025
12.

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

Neuzil J, Dyason JC, Freeman R, Dong LF, Prochazka L, Wang XF, Scheffler I, Ralph SJ.

J Bioenerg Biomembr. 2007 Feb;39(1):65-72. Review.

PMID:
17294131
13.

Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid.

Solá S, Aranha MM, Steer CJ, Rodrigues CM.

Curr Issues Mol Biol. 2007 Jul;9(2):123-38. Review.

14.

Mitochondria as cancer drug targets.

Don AS, Hogg PJ.

Trends Mol Med. 2004 Aug;10(8):372-8. Review.

PMID:
15310457
15.

Mitochondriotoxic compounds for cancer therapy.

Fantin VR, Leder P.

Oncogene. 2006 Aug 7;25(34):4787-97. Review.

PMID:
16892091
16.

Yessotoxin as an apoptotic inducer.

Korsnes MS, Espenes A.

Toxicon. 2011 Jun;57(7-8):947-58. doi: 10.1016/j.toxicon.2011.03.012. Epub 2011 Mar 21. Review.

PMID:
21426912
17.

Therapeutic targets in the mitochondrial apoptotic pathway.

Häcker G, Paschen SA.

Expert Opin Ther Targets. 2007 Apr;11(4):515-26. Review.

PMID:
17373881
18.

Do reactive oxygen species play a role in myeloid leukemias?

Hole PS, Darley RL, Tonks A.

Blood. 2011 Jun 2;117(22):5816-26. doi: 10.1182/blood-2011-01-326025. Epub 2011 Mar 11. Review. Erratum in: Blood. 2014 Jan 30;123(5):798.

19.

Small mitochondria-targeting molecules as anti-cancer agents.

Wang F, Ogasawara MA, Huang P.

Mol Aspects Med. 2010 Feb;31(1):75-92. doi: 10.1016/j.mam.2009.12.003. Epub 2009 Dec 6. Review.

20.

Hyperbaric oxygen: a potential new therapy for leukemia?

Tonomura N, Granowitz EV.

Leuk Res. 2007 Jun;31(6):745-6. Epub 2007 Feb 2. Review. No abstract available.

PMID:
17275904
Items per page

Supplemental Content

Write to the Help Desk